Conical Polyurethane Implants
نویسندگان
چکیده
منابع مشابه
Conical polyurethane implants: an uplifting augmentation.
BACKGROUND Polyurethane-coated conical implants were introduced by Silimed (US distributor: Sientra, Santa Barbara, California) in 2008 and offer an alternative to round or anatomically shaped implants. By their design and volume distribution, they naturally create central volume and give a reasonable fullness to the upper pole while lifting some ptotic breasts, thus avoiding the need for class...
متن کاملLifetime risk from polyurethane covered breast implants.
The recent article by Luu et al. (1) predicting an excess lifetime risk from polyurethane covered breast implants of 1 in 400,000 is based upon numerous questionable assumptions and cannot go unchallenged. I have listed below several of the more obvious problems with this study and its conclusions. The estimated dose of polyurethane was too high. The authors use a weight of foam in their dosage...
متن کاملPolyurethane-Coated Breast Implants Revisited: A 30-Year Follow-Up
BACKGROUND Polyurethane coating of breast implants has been shown to reduce capsular contracture in short-term follow-up studies. This 30-year study is the longest examination of the use of polyurethane-coated implants and their correlation with capsular contracture. METHODS This study evaluates the senior surgeon's (F.D.P.) experience with the use of polyurethane-coated implants in aesthetic...
متن کاملFeasibility of conical biodegradable polyurethane foam for closure of oroantral communications.
PURPOSE To assess the feasibility of a conically shaped biodegradable polyurethane (PU) foam for closure of oroantral communications (OACs). PATIENTS AND METHODS In 10 consecutive patients, fresh OACs (present for <24 hours) were closed with PU foam. Standardized evaluations were performed at 2 and 8 weeks after closure of the OAC. Success was considered permanent closure of the OAC. RESULT...
متن کاملA physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants.
Physiologically based pharmacokinetic (PBPK) modeling was used to assess the low-dose exposure of patients to the carcinogen 2, 4-toluenediamine (2,4-TDA) released from the degradation of the polyester urethane foam (PU) used in Meme silicone breast implants. The tissues are represented as five compartments: liver, kidney, gastrointestinal tract, slowly perfused tissues (e.g., fat), and richly ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Aesthetic Surgery Journal
سال: 2013
ISSN: 1090-820X,1527-330X
DOI: 10.1177/1090820x13512855